ConforMIS Expands Intellectual Product Portfolio with 22 Issued Patents

BURLINGTON, Mass.--(BUSINESS WIRE)--ConforMIS, Inc. today announced it has completed its most productive period to date in the development of its intellectual property with the addition of 22 issued patents to its portfolio since January 2011. The core of its portfolio covers patient-specific implants and patient-specific instrumentation systems spanning applications in knee, hip, shoulder, small joint, and spine. With these recent patent awards, ConforMIS now owns or exclusively licenses more than 50 issued patents.

Back to news